Epclusa 28s

Patent medicine name

Epclusa 28s

Manufacturer

Gilead Sciences Ltd

Specification

Physical Form: Tablets, Quantity: 28pill/bottle, Storage: Room Temperature(10-30°C)

Price

$26000- 26050

Generic medicine name & Manufacturer

VelaKast 28 Tablet, Aprazer

Specification

Physical Form: Tablets, Quantity: 28pill/bottle, Storage: Room Temperature(10-30°C)

Price

$180-200

Composition

Sofosbuvir 400mg + Velpatasvir 100mg

Use

The fixed-dose combination sofosbuvir-velpatasvir (400 mg/100 mg) is FDA-approved for the treatment of chronic hepatitis C genotypes 1 to 6 for the following patient populations: Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A)

Medicince introduction including background, function, caution, etc.

Indication
It is used in the treatment of chronic hepatitis C virus (HCV) infection.

Side effects
Headache, Tiredness.

Mechanisam of Action
It is a combination of two antiviral medicines: Sofosbuvir 400mg and Velpatasvir 100mg. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Use in Other language

Picture